Top Markets
Coin of the day
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO
Hisse Senetlerindeki Sıralama #78
Thermo Fisher Scientific Inc. is a global leader in scientific services,... Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Hisse Fiyatı
$607.17
Son senkronizasyon: 2026-09-09
Piyasa Değeri
$225.64B
Değişim (1 gün)
0.53%
Değişim (1 yıl)
27.41%
Ülke
US
Ticaret Thermo Fisher Scientific Inc. (TMO)

Kategori

Thermo Fisher Scientific Inc. (TMO) için kazanç
Jun 2026 itibarıyla kazanç TTM: $7.61B
Thermo Fisher Scientific Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $7.61B'dir. 2024 yılında şirket $7.00B kazanç elde etti, bu 2023 yılındaki $6.24B kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Thermo Fisher Scientific Inc. için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $7.61B 4.71%
2025 $7.27B 3.89%
2024 $7.00B 12.12%
2023 $6.24B -18.58%
2022 $7.66B -13.29%
2021 $8.84B 22.28%
2020 $7.23B 77.57%
2019 $4.07B 24.77%
2018 $3.26B 34.29%
2017 $2.43B 20.02%
2016 $2.02B 4.52%
2015 $1.94B -7.22%
2014 $2.09B 58.18%
2013 $1.32B 3.95%
2012 $1.27B 12.06%
2011 $1.13B 4.15%
2010 $1.09B 17.32%
2009 $927.10M -19.35%
2008 $1.15B 30.44%
2007 $881.30M 320.93%
2006 $209.37M -26.77%
2005 $285.90M 10.29%
2004 $259.22M 18.56%
2003 $218.63M -24.08%
2002 $287.99M 276.35%
2001 $76.52M -56.09%
2000 $174.26M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$4.76B -37.42%
US
- -
CN
$-252.70M -103.32%
US
$1.61B -78.85%
US
$1.66B -78.21%
US